Acasti Pharma -a- (ACST) Reports Q3 Loss of $0.02/Share
Tweet
Share
E-mailGet Alerts ACST Hot Sheet
Join SI Premium – FREE
Acasti Pharma -a- (NASDAQ: ACST) reported Q3 EPS of ($0.02), versus ($0.03) reported last year.
For earnings history and earnings-related data on Acasti Pharma -a- (ACST) click here.
For earnings history and earnings-related data on Acasti Pharma -a- (ACST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Marchex (MCHX) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
